Pulmonary embolism accounts for 10–15% of all paediatric venous thromboembolism (VTE) events, with an annual incidence of 0·14–0·9 per 100 000 children.1,2 Although rare, pulmonary embolism is a ...
DVT prophylaxis reduces the risk of developing deep vein thrombosis through medications, compression stockings, and devices. Deep vein thrombosis (DVT) can occur when a blood clot forms in a deep vein ...
Healthcare professionals create care plans to help manage conditions such as pulmonary embolism. Planning may help improve outcomes and prevent future occurrences of the condition. Care plans are an ...
The disadvantages of dabigatran include a higher cost compared with warfarin, the need for twice-daily dosing, and a slightly increased risk for gastrointestinal bleeding (6.1% with dabigatran vs 4% ...
Apixaban and rivaroxaban are the oral anticoagulants most frequently used to treat acute venous thromboembolism. However, uncertainty remains about the difference in bleeding risk between the two ...
A subsegmental pulmonary embolism is a blood clot located on a distal, or distant and less central, branch of the pulmonary arteries. Treatment can depend on symptoms and risk factors. A subsegmental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results